Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Unknown 2Terminated 2

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 14Gynecologic 6Head & Neck 5Thoracic 4Breast 3Other solid neoplasm 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Thymoma 1Thymic epithelial tumor 1Lung Neoplasms 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × TP protocol × Thoracic × Clear all
NCT01393080 2016-02-17

NSCLC

Tianjin Medical University Cancer Institute and Hospital

Phase NA Unknown
160 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00801736 2013-12-10

ET

University College, London

Phase 3 Terminated
648 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01902875 2013-07-18

Preconditioning Chemotherapy Combination With Cytokine Induced Killer Cell (CIK) Immunotherapy

Jinling Hospital, China

Unknown
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00818090 2013-04-12

Paclitaxel and Cisplatin for Thymic Neoplasm

Korean Cancer Study Group

Phase 2 Terminated
39 enrolled
Thoracic

Thymic epithelial tumor, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡